-18.8%
PATH vs THC
+429.4%
-448.2%
-65.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.9% | +9.6% | -6.7% | +1.0% |
| 7D | -4.8% | +8.8% | -13.6% | -6.4% |
| 30D | +2.7% | +12.6% | -10.0% | +0.3% |
| 3M | -4.2% | +15.4% | -19.5% | -7.1% |
| 6M | +24.7% | +57.7% | -32.9% | +13.5% |
| YTD | -17.6% | +47.1% | -64.6% | -24.9% |
| 1Y | -5.3% | +40.7% | -46.0% | -12.8% |
| All | -18.8% | +429.4% | -448.2% | -63.5% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling